Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.64 USD | -1.79% |
|
-8.62% | +38.65% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.83 | +58.05% | 6 | ||||||
| 680.7 | +21.51% | 23 | ||||||
| 207 | +12.59% | 21 | ||||||
| 415.64 | +25.78% | 27 | ||||||
| 249.63 | +2.75% | 19 | ||||||
| 264,382.94 | +49.03% | 24 | ||||||
| 267.77 | +19.66% | 18 | ||||||
| 581.83 | +1.9% | 12 | ||||||
| 72.6 | +5.95% | 14 | ||||||
| 181.81 | +0.87% | 16 | ||||||
| 70 | -2.87% | 12 | ||||||
| 138.56 | +27.35% | 6 | ||||||
| 230.93 | -3.95% | 15 | ||||||
| 130.53 | -2.71% | 12 | ||||||
| 37.73 | +0.03% | 11 | ||||||
| 91.65 | +65.73% | 20 | ||||||
| 127.52 | +20.12% | 21 | ||||||
| 610.05 | +106.23% | 19 | ||||||
| 55.35 | +9.61% | 17 | ||||||
| 133.31 | -2.58% | 13 | ||||||
| Average | 13,435.02 | +20.75% | 16 | ||||||
| Weighted average by Cap. | 21,378.55 | +18.30% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
